Results 191 to 200 of about 161,532 (251)
ABSTRACT Background Anal cancer rates are rising among women, immunocompromised individuals, and Men who have sex with Men (MSM), independent of HIV status. While high‐resolution anoscopy remains the diagnostic standard, limited access has increased interest in alternative screening.
Daisy Maharjan +5 more
wiley +1 more source
Head and neck cancer therapeutic vaccines: a review. [PDF]
Huetteman A, Rabinowits G.
europepmc +1 more source
Abstract Background Streptococcus equi subspecies zooepidemicus is a highly diverse opportunistic pathogen of horses, associated with respiratory disease and endometritis. Objectives To characterise S. zooepidemicus isolates recovered from young ponies during a natural episode of respiratory disease, and to determine if vaccination with Strangvac®, a ...
Romain Paillot +8 more
wiley +1 more source
The research progress of gastric cancer vaccines: a narrative review. [PDF]
Wu H, Zhang F, Shao Q, Huang Z.
europepmc +1 more source
An Ocular Surface‐Targeting Nucleic Acid Hydrogel for Efficient Dry Eye Disease Treatment
A self‐assembled nucleic acid hydrogel modified with mucin‐1 (MUC1) aptamer is developed, which can actively target the mucin layer on the ocular surface and significantly extend its retention time after distillation. Inside the hydrogel, therapeutic siRNA is embedded and can effectively silence the inflammation gene expression, subsequently restoring ...
Yuhe Liu +12 more
wiley +1 more source
Strain-specific detection of Mycoplasma gallisepticum: A duplex qPCR assay for vaccine efficacy and infection surveillance. [PDF]
Fan P +7 more
europepmc +1 more source
Enhancing Optogenetics‐Based Cancer Therapy Via Nanotechnology
Nanotechnology enhances optogenetics‐based cancer therapy through improved delivery systems and non‐invasive optical regulation. It further enables precise and programmable control of optogenetic living therapeutics for localized antitumor responses.
Honggang Shen +8 more
wiley +1 more source
<i>Haemophilus influenzae:</i> imposter, mucosal pathobiont, and model organism. [PDF]
Amero K, St Geme JW.
europepmc +1 more source
Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC). [PDF]
Kyriakopoulos CE +5 more
europepmc +1 more source
TTV Viremia and Immune Responses Following Vaccination Against Mpox and Dengue Viruses. [PDF]
Minosse C +17 more
europepmc +1 more source

